Zusammenfassung
Mikrobiell verursachte Endokarditiden kommen in den westlichen Industrieländern in einer Inzidenz von 3–5/100.000 Einwohnern vor. Es handelt sich um endovaskuläre, vorzugsweise durch Bakterien verursachte Infektionen kardiovaskulärer Strukturen, insbesondere der Herzklappen, aber auch intrakardial implantierter Fremdmaterialien. Die Letalität der Endokarditis ist unverändert hoch und beträgt bis zu 20%. Eine besonders gefürchtete Komplikation stellen zerebrale Embolien dar. Systemische Embolien werden für 20–50% aller Endokarditiden beschrieben; hierbei betreffen bis zu 65% das ZNS und über 90% das Strömungsgebiet der A. cerebri media. Erschreckend sind auch lange mittlere stationäre Behandlungszeiten, die bei über 40 Tagen liegen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Baddour LM, Wilson WR, Bayer AS et al. (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111: e394–434. www.circ.ahajournals.org/cgi/content/full/111/23/e394
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer
Habib G, Hoen B, Tornos P et al. (2009) ESC Committee for Practice Guidelines. Eur Heart J 30(19): 2369–2413. Epub 2009 Aug 27
Hoen B (2006) Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart 92: 1694–700
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Wilson W, Taubert KA, Gewitz M et al. (2007) American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007; 116: 1736–1754
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Flesc, M. (2011). Erregerbedingte Endokarditiden. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16481-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-16481-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16480-4
Online ISBN: 978-3-642-16481-1
eBook Packages: Medicine (German Language)